マルチオミクス市場：製品タイプ、用途、エンドユーザー別-2025～2030年の世界予測

マルチオミクス市場は、2023年に835億5,000万米ドルと評価され、2024年には968億6,000万米ドルに達すると予測され、CAGR 16.26%で成長し、2030年には2,399億2,000万米ドルに達すると予測されています。

マルチオミクスは、ゲノミクス、トランスクリプトミクス、プロテオミクス、メタボロミクスといった複数の「オミクス」技術を統合し、細胞、組織、生物の分子コンポーネントを包括的に把握する生物学研究セグメントの包括的アプローチです。マルチオミクスの必要性は、生物学的システムの複雑な性質と、さまざまな分子コンポーネントがどのように相互作用し、健康状態や疾病状態に寄与しているかを理解する必要性から生じています。その応用範囲は、個別化医療、バイオマーカー探索、医薬品開発、農業など多岐にわたります。

調査対象範囲には、製薬、バイオテクノロジー企業、研究機関、病院、クリニックが含まれます。マルチオミクスは、創薬や治療開発において極めて重要な役割を果たすと同時に、より的を絞った治療や個別化された治療計画を可能にし、精密医療の進歩に不可欠であることが証明されています。さらに、作物の品種改良と回復力を強化することで農業バイオテクノロジーにも役立ち、食糧安全保障に大きく貢献しています。

市場開拓の要因としては、オミクス技術の進歩、研究開発投資の増加、慢性疾患の蔓延、個別化医療の重視の高まりなどが挙げられます。主要ビジネス機会は、精密医療に対する需要の高まり、新興市場、分析を強化するためのマルチオミクスデータと人工知能の統合に見出すことができます。学術機関とバイオテクノロジー企業とのパートナーシップの拡大も大きな後押しとなる可能性があります。

しかし、市場成長は、オミクス技術に関連する高コスト、複雑なデータ解釈、先進的バイオインフォマティクスの専門知識の必要性などの課題に直面しています。プライバシーに関する懸念や規制上の制約が、研究や応用をさらに複雑にしています。

イノベーションと研究は、より費用対効果が高くスケーラブルなオミクス技術の開発、データ統合方法の改善、より良いデータ分析のためのバイオインフォマティクスツールの強化に焦点を当てることができます。これらのセグメントを最適化することで、既存の課題に対処し、市場拡大を促進することができると考えられます。市場は競合が多いもの、システム生物学などの新興セグメントに注力し、部門を超えた協力関係を促進して専門知識を結集し、新興技術を活用することで、大きく成長する可能性が残されています。

市場力学：急速に進化するマルチオミクス市場の主要市場洞察を公開

マルチオミクス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • NGS、質量分析ベースのプロテオミクス、遺伝子発現プロファイリングプラットフォームの進歩の増加
  • 個別化医療への嗜好の高まりによる高い可能性
  • バイオテクノロジー企業による研究開発の活発化
• 市場抑制要因
  • マルチオミクスに関連する高コストと限られた熟練専門家
• 市場機会
  • 先端技術のマルチオミクスへの統合の増加
  • 持続可能性を目標とした農業研究と環境科学への投資の増加
• 市場課題
  • オミクス研究におけるデータ取得、保存、共有のための標準プロトコルが限定的

ポーターのファイブフォース：マルチオミクス市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：マルチオミクス市場における外部からの影響の把握

外部マクロ環境要因は、マルチオミクス市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：マルチオミクス市場における競合情勢の把握

マルチオミクス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：マルチオミクス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、マルチオミクス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：マルチオミクス市場における成功への道筋を描く

マルチオミクス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • NGS、質量分析別のプロテオミクス、遺伝子発現プロファイリングプラットフォームの進歩
    • パーソナライズされた医薬品への嗜好の高まりにより、高い潜在性がある
    • バイオテクノロジー企業による研究開発活動の増加
  • 抑制要因
    • マルチオミクスに関連する高コストと限られた熟練専門家
  • 機会
    • 先進技術のマルチオミクスへの統合の拡大
    • 持続可能性目標を掲げた農業調査と環境科学への投資増加
  • 課題
    • オミクス研究におけるデータの取得、保存、共有のための標準プロトコルが限られている
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 マルチオミクス市場：製品別

• イントロダクション
• 消耗品
• 機器
• ソフトウェア

第7章 マルチオミクス市場：タイプ別

• イントロダクション
• エピゲノミクス
• ゲノミクス
• メタボロミクス
• マイクロバイオミクス
• プロテオミクス
• トランスクリプトミクス

第8章 マルチオミクス市場：用途別

• イントロダクション
• 農業と植物科学
• 診断
• 創薬
• 精密医療

第9章 マルチオミクス市場：エンドユーザー別

• イントロダクション
• 学術研究機関
• バイオテクノロジー企業
  • 農業
  • 環境科学
  • 法医学
  • 植物と動物の育種
• 病院・クリニック
• 製薬・バイオ医薬品企業

第10章 南北アメリカのマルチオミクス市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋のマルチオミクス市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのマルチオミクス市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年年
• 競合シナリオ分析
  • MultiOmic Health、メタボリックシンドローム関連疾患の精密医薬品開発に向け620万米ドルの資金調達ラウンドを完了
  • Biomodalが新しいマルチオミクスシーケンス技術を発表
  • Tempus、Actuate Therapeuticsとの新たなマルチオミクスコラボレーションを発表
  • BD、科学的発見の範囲を拡大する高性能シングルセルマルチオミクスプラットフォームを発表
• 戦略分析と提言

企業一覧

• 10x Genomics, Inc.
• AstraZeneca PLC
• Becton, Dickinson and Company
• Berkeley Lights, Inc.
• BGI Genomics Co. Ltd
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• BioLegend, Inc. by PerkinElmer, Inc.
• Celsee
• Charles River Laboratories International, Inc.
• Danaher Corporation
• Dolomite Bio by Unchained Labs
• EpiCypher, Inc.
• Google LLC by Alphabet Inc.
• Illumina, Inc.
• Miltenyi BIoTec
• Mission Bio, Inc.
• Multiomic Health Limited
• NanoCellect Biomedical
• NanoString Technologies, Inc.
• Novo Nordisk A/S
• Olink Proteomics AB
• QIAGEN N.V.
• Shimadzu Corporation
• Singleron BIoTechnologies GmbH
• Standard BioTools Inc.
• TAKARA BIO INC.
• Tempus Labs, Inc.
• Thermo Fischer Scientific Inc.

LIST OF FIGURES

• FIGURE 1. MULTIOMICS MARKET RESEARCH PROCESS
• FIGURE 2. MULTIOMICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MULTIOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MULTIOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MULTIOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MULTIOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MULTIOMICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MULTIOMICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL MULTIOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL MULTIOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL MULTIOMICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL MULTIOMICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES MULTIOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES MULTIOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. MULTIOMICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. MULTIOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MULTIOMICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MULTIOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MULTIOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MULTIOMICS MARKET DYNAMICS
• TABLE 7. GLOBAL MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MULTIOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MULTIOMICS MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MULTIOMICS MARKET SIZE, BY EPIGENOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MULTIOMICS MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MULTIOMICS MARKET SIZE, BY METABOLOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MULTIOMICS MARKET SIZE, BY MICROBIOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL MULTIOMICS MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL MULTIOMICS MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL MULTIOMICS MARKET SIZE, BY AGRICULTURE & PLANT SCIENCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL MULTIOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL MULTIOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL MULTIOMICS MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL MULTIOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL MULTIOMICS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL MULTIOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL MULTIOMICS MARKET SIZE, BY FORENSICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL MULTIOMICS MARKET SIZE, BY PLANT & ANIMAL BREEDING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL MULTIOMICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL MULTIOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 49. CANADA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. CANADA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. CANADA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. CANADA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. CANADA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES MULTIOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 76. CHINA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. CHINA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. CHINA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. CHINA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. CHINA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 81. INDIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. INDIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. INDIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. INDIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. INDIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. INDONESIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. INDONESIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. JAPAN MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. JAPAN MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. MALAYSIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. MALAYSIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. PHILIPPINES MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. PHILIPPINES MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. SINGAPORE MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. SINGAPORE MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. SOUTH KOREA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. SOUTH KOREA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. TAIWAN MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. TAIWAN MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. THAILAND MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. THAILAND MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. VIETNAM MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. VIETNAM MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 136. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. DENMARK MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. DENMARK MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. EGYPT MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. EGYPT MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. FINLAND MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. FINLAND MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. FRANCE MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. FRANCE MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. GERMANY MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. GERMANY MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. ISRAEL MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. ISRAEL MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 167. ITALY MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. ITALY MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 169. ITALY MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. ITALY MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. ITALY MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. NETHERLANDS MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. NETHERLANDS MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. NIGERIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. NIGERIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. NORWAY MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. NORWAY MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 187. POLAND MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. POLAND MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 189. POLAND MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. POLAND MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. POLAND MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 192. QATAR MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. QATAR MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 194. QATAR MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. QATAR MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 196. QATAR MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 200. RUSSIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 201. RUSSIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 206. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 210. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. SPAIN MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 216. SPAIN MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 220. SWEDEN MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 221. SWEDEN MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 225. SWITZERLAND MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 226. SWITZERLAND MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 230. TURKEY MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 231. TURKEY MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 235. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 236. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 240. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 241. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 242. MULTIOMICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 243. MULTIOMICS MARKET, FPNV POSITIONING MATRIX, 2023

The Multiomics Market was valued at USD 83.55 billion in 2023, expected to reach USD 96.86 billion in 2024, and is projected to grow at a CAGR of 16.26%, to USD 239.92 billion by 2030.

Multiomics is a comprehensive approach within the field of biological research that integrates multiple "omics" technologies, such as genomics, transcriptomics, proteomics, and metabolomics, to provide an all-encompassing view of the molecular constituents of cells, tissues, and organisms. The necessity of multiomics arises from the complex nature of biological systems and the need to understand how different molecular components interact and contribute to health and disease states. Its applications span personalized medicine, biomarker discovery, drug development, and agriculture.

The end-use scope includes pharmaceuticals, biotechnology companies, research institutions, hospitals, and clinics. Multiomics has proven essential for advancing precision medicine, allowing for more targeted therapies and personalized treatment plans, while playing a pivotal role in drug discovery and therapeutic development. Moreover, it helps in agricultural biotechnology by enhancing crop breeding and resilience, contributing significantly to food security.

Market growth factors include advancements in omics technologies, increased investment in research and development, the prevalence of chronic diseases, and a growing emphasis on personalized healthcare. Key opportunities can be found in the rising demand for precision medicine, emerging markets, and the integration of artificial intelligence with multiomics data for enhanced analytics. Expanding partnerships between academic institutions and biotechnology firms could also offer a significant boost.

However, market growth faces challenges such as high costs associated with omics technologies, complex data interpretation, and the need for high-level bioinformatics expertise. Privacy concerns and regulatory constraints further complicate multiomics research and application.

Innovation and research could focus on developing more cost-effective and scalable omics technologies, improving data integration methods, and enhancing bioinformatics tools for better data analysis. Optimizing these areas would address existing challenges and drive market expansion. Despite the competitive nature of the market, there remains potential for significant growth by focusing on emerging fields such as systems biology and by fostering collaborations across sectors to harness collective expertise and leverage emerging technologies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Multiomics Market

The Multiomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing advancements in NGS, mass spectrometry-based proteomics, and gene expression profiling platforms
  • High potential owing to a growing preference towards personalized medicines
  • Rising research & development activities conducted by biotechnology companies
• Market Restraints
  • High cost and limited skilled professionals associated with multiomics
• Market Opportunities
  • Growing integration of advanced technologies into multiomics
  • Increasing investments in agriculture research and environmental science with sustainability targets
• Market Challenges
  • Limited standard protocols for data acquisition, storage, and sharing across omics studies

Porter's Five Forces: A Strategic Tool for Navigating the Multiomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Multiomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Multiomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Multiomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Multiomics Market

A detailed market share analysis in the Multiomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Multiomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Multiomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Multiomics Market

A strategic analysis of the Multiomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Multiomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., AstraZeneca PLC, Becton, Dickinson and Company, Berkeley Lights, Inc., BGI Genomics Co. Ltd, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioLegend, Inc. by PerkinElmer, Inc., Celsee, Charles River Laboratories International, Inc., Danaher Corporation, Dolomite Bio by Unchained Labs, EpiCypher, Inc., Google LLC by Alphabet Inc., Illumina, Inc., Miltenyi Biotec, Mission Bio, Inc., Multiomic Health Limited, NanoCellect Biomedical, NanoString Technologies, Inc., Novo Nordisk A/S, Olink Proteomics AB, QIAGEN N.V., Shimadzu Corporation, Singleron Biotechnologies GmbH, Standard BioTools Inc., TAKARA BIO INC., Tempus Labs, Inc., and Thermo Fischer Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Multiomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables, Instrument, and Software.
• Based on Type, market is studied across Epigenomics, Genomics, Metabolomics, Microbiomics, Proteomics, and Transcriptomics.
• Based on Application, market is studied across Agriculture & Plant Science, Diagnostics, Drug Discovery, and Precision Medicine.
• Based on End-User, market is studied across Academic & Research Institutes, Biotechnology Companies, Hospitals & Clinics, and Pharmaceutical & Biopharmaceutical Companies. The Biotechnology Companies is further studied across Agriculture, Environmental Science, Forensics, and Plant & Animal Breeding.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing advancements in NGS, mass spectrometry-based proteomics, and gene expression profiling platforms
    • 5.1.1.2. High potential owing to a growing preference towards personalized medicines
    • 5.1.1.3. Rising research & development activities conducted by biotechnology companies
  • 5.1.2. Restraints
    • 5.1.2.1. High cost and limited skilled professionals associated with multiomics
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing integration of advanced technologies into multiomics
    • 5.1.3.2. Increasing investments in agriculture research and environmental science with sustainability targets
  • 5.1.4. Challenges
    • 5.1.4.1. Limited standard protocols for data acquisition, storage, and sharing across omics studies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Multiomics Market, by Product

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Instrument
• 6.4. Software

7. Multiomics Market, by Type

• 7.1. Introduction
• 7.2. Epigenomics
• 7.3. Genomics
• 7.4. Metabolomics
• 7.5. Microbiomics
• 7.6. Proteomics
• 7.7. Transcriptomics

8. Multiomics Market, by Application

• 8.1. Introduction
• 8.2. Agriculture & Plant Science
• 8.3. Diagnostics
• 8.4. Drug Discovery
• 8.5. Precision Medicine

9. Multiomics Market, by End-User

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Biotechnology Companies
  • 9.3.1. Agriculture
  • 9.3.2. Environmental Science
  • 9.3.3. Forensics
  • 9.3.4. Plant & Animal Breeding
• 9.4. Hospitals & Clinics
• 9.5. Pharmaceutical & Biopharmaceutical Companies

10. Americas Multiomics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Multiomics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Multiomics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. MultiOmic Health Closes USD 6.2 Million Funding Round to Discover Precision Medicines for Metabolic Syndrome-Related Conditions
  • 13.3.2. Biomodal Launches New Multiomics Sequencing Technology
  • 13.3.3. Tempus Announces New Multi-omics Collaboration with Actuate Therapeutics
  • 13.3.4. BD Introduces High-Throughput Single-Cell Multiomics Platform to Expand Scope of Scientific Discovery
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 10x Genomics, Inc.
• 2. AstraZeneca PLC
• 3. Becton, Dickinson and Company
• 4. Berkeley Lights, Inc.
• 5. BGI Genomics Co. Ltd
• 6. Bio-Rad Laboratories, Inc.
• 7. Bio-Techne Corporation
• 8. BioLegend, Inc. by PerkinElmer, Inc.
• 9. Celsee
• 10. Charles River Laboratories International, Inc.
• 11. Danaher Corporation
• 12. Dolomite Bio by Unchained Labs
• 13. EpiCypher, Inc.
• 14. Google LLC by Alphabet Inc.
• 15. Illumina, Inc.
• 16. Miltenyi Biotec
• 17. Mission Bio, Inc.
• 18. Multiomic Health Limited
• 19. NanoCellect Biomedical
• 20. NanoString Technologies, Inc.
• 21. Novo Nordisk A/S
• 22. Olink Proteomics AB
• 23. QIAGEN N.V.
• 24. Shimadzu Corporation
• 25. Singleron Biotechnologies GmbH
• 26. Standard BioTools Inc.
• 27. TAKARA BIO INC.
• 28. Tempus Labs, Inc.
• 29. Thermo Fischer Scientific Inc.